drugset / Trial / NCT05126628
The South Proxa-Rescue AndroCoV Trial Against COVID-19
Phase 3
Completed
133 enrolled
Corpometria Institute
Hospital Arcanjo Sao Miguel, Gramado, Brazil · collabHospital Unimed Chapeco, Chapeco, Brazil · collabHospital da Brigada Militar de Porto Alegre, Porto Alegre, Brazil · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the efficacy of proxalutamide or hospitalized moderate-to-severe COVID-19 patients.
Timeline
- Start
- 2021-03-06
- Primary completion
- 2021-03-16
- Completion
- 2021-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | PRUXELUTAMIDE | Small molecule | 300 mg | — |